Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

M&A Buzz In Korea: CJ HealthCare On the Block

Executive Summary

CJ Group plans to sell its healthcare affiliate, in what could potentially emerge as the first major M&A deal involving a South Korean pharma firm in recent years. Although the company has not ruled out the option of an initial public offering as an alternative, the sale plan possibly reflects the changing dynamics in the Korean pharma industry.

Advertisement

Related Content

Kolmar Korea Eyes Pharma Expansion Via CJ HealthCare Acquisition
Korea 2017 Review: Biosimilar Advances, R&D Progress Restore Confidence
Korea 2017 Review: Biosimilar Advances, R&D Progress Restore Confidence
Deal Watch: Boehringer’s Hectic Stretch Adds Up To Five Deals
What's Driving The Uptick In Korea-China Biotech Deals

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC099821

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel